Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
BWAY
BWAY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BWAY News
BrainsWay to Announce Q4 Earnings on March 11
4h ago
seekingalpha
GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand
5d ago
PRnewswire
GAD Therapies Market Expected to Reach $4.26B by 2033 Amid Rising Demand
5d ago
Newsfilter
Investment Opportunities in Oversold Healthcare Stocks
5d ago
Benzinga
BrainsWay Unveils New Noninvasive Depression Treatment Protocol
6d ago
Newsfilter
BrainsWay to Report Q4 and Full Year 2025 Results on March 11
Feb 25 2026
Yahoo Finance
BrainsWay Makes $2.5M Investment in BrainStim Health
Feb 19 2026
seekingalpha
BrainsWay Enters Strategic Investment Agreement with BrainStim Health
Feb 19 2026
Newsfilter
BrainsWay Shares Rise as Cigna Removes TMS Authorization Requirements
Feb 18 2026
seekingalpha
BrainsWay Partners with Evernorth to Enhance TMS Accessibility
Feb 18 2026
Newsfilter
BrainsWay Changes ADS Ratio to 1:1 Structure
Feb 17 2026
seekingalpha
BrainsWay Adjusts ADS Ratio to Simplify Capital Structure
Feb 17 2026
Newsfilter
Wall Street Analysts Adjust Ratings on Key Stocks
Jan 26 2026
Benzinga
BrainsWay Secures Expanded Coverage for Depression Treatment from Highmark
Jan 21 2026
Globenewswire
BrainsWay (BWAY) Receives FDA Approval for Proliv™Rx System for Depression Treatment
Jan 12 2026
Globenewswire
BrainsWay to Host Virtual Analyst & Investor Day on December 1, 2025
Nov 25 2025
Newsfilter
Show More News
